{"id":"W2929513598","doi":"10.1093/annonc/mdz113","title":"Phase Ib study of atezolizumab combined with cobimetinib in patients with solid tumors","year":2019,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":190,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; Roche (Canada); University of Toronto; University Health Network; Centre Hospitalier de l’Université de Montréal; McGill University; Jewish General Hospital","funders":"National Cancer Institute; Genentech","keywords":"Atezolizumab; Medicine; Tolerability; Internal medicine; Adverse effect; Oncology; Lung cancer; Rash; Discontinuation; Nivolumab; Gastroenterology; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001197087,0.001701893,0.00306889,0.000498201,0.0005534962,0.001639888,0.0009343005,0.001526101,0.003599607],"category_scores_gemma":[0.0007384042,0.0007652999,0.002476368,0.0004893629,0.001124998,0.001292036,0.0004713406,0.005282857,0.001413616],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001325592,"about_ca_system_score_gemma":0.001921908,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001617876,"about_ca_topic_score_gemma":0.004140076,"domain_scores_codex":[0.9996344,0.0001311198,0.00001783022,0.00007451227,0.00002537271,0.0001167253],"domain_scores_gemma":[0.999521,0.00006809824,0.00006976442,0.00004604814,0.00003366166,0.0002613517],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7956262,0.05040078,0.005157936,0.001119175,0.002687063,0.0002124239,0.000237013,0.003189436,0.0261188,0.0003735002,0.005687688,0.10919],"study_design_scores_gemma":[0.67089,0.3125276,0.006712073,0.00005741436,0.001034365,0.0002721635,0.0001058322,0.001374401,0.00272438,0.0002292047,0.004037859,0.00003473587],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9870145,0.005092792,0.0006427027,0.001293547,0.0004492813,0.001641453,0.001399808,0.0001183486,0.002347527],"genre_scores_gemma":[0.9851871,0.003720887,0.001364096,0.001259125,0.0002950175,0.00190867,0.003003747,0.00004301969,0.003218279],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003599607,"threshold_uncertainty_score":0.01204193,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03361865556179713,"score_gpt":0.3662232353398603,"score_spread":0.3326045797780632,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}